The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 2701427)

Published in BMC Psychiatry on May 27, 2009

Authors

Bruno Fantino1, Nicholas Moore

Author Affiliations

1: ADIM-AGORAS, Lyon, France. bruno.fantino@wanadoo.fr

Articles citing this

A comparison of psychometric properties between internet and paper versions of two depression instruments (BDI-II and MADRS-S) administered to clinic patients. J Med Internet Res (2010) 1.46

Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.17

Phase 1 pilot study of e-mail support for people with long term conditions using the Internet. BMC Med Inform Decis Mak (2011) 0.91

Citalopram versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2012) 0.87

Deep brain stimulation of the ventral striatum/anterior limb of the internal capsule in thalamic pain syndrome: study protocol for a pilot randomized controlled trial. Trials (2013) 0.87

Using patient-centred consultation when screening for depression in elderly patients: a comparative pilot study. Scand J Prim Health Care (2011) 0.84

Multimodal behavioral treatment of migraine: an Internet-administered, randomized, controlled trial. Ups J Med Sci (2011) 0.83

The impact of anxiety, depression, and suicidality on quality of life and functional status of patients with congestive heart failure and hypertension: an observational cross-sectional study. Prim Care Companion J Clin Psychiatry (2010) 0.82

Internet-delivered therapist-guided physical activity for mild to moderate depression: a randomized controlled trial. PeerJ (2013) 0.81

Comparison Between the Montgomery-Asberg Depression Rating Scale-Self and the Beck Depression Inventory II in Primary Care. Prim Care Companion CNS Disord (2015) 0.80

The effects of a rhythm and music-based therapy program and therapeutic riding in late recovery phase following stroke: a study protocol for a three-armed randomized controlled trial. BMC Neurol (2012) 0.79

Course, risk factors, and prognostic factors in elderly primary care patients with mild depression: a two-year observational study. Scand J Prim Health Care (2013) 0.79

Using early change to predict outcome in cognitive behaviour therapy: exploring timeframe, calculation method, and differences of disorder-specific versus general measures. PLoS One (2014) 0.78

Internet-Based Cognitive Behavioral Therapy for Residual Symptoms in Bipolar Disorder Type II: A Single-Subject Design Pilot Study. JMIR Res Protoc (2015) 0.78

A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression - A Pilot Study. Front Neurol (2016) 0.75

Patients' perspectives on the use of the Montgomery-Asberg depression rating scale self-assessment version in primary care. Scand J Prim Health Care (2016) 0.75

Use of a self-rating scale to monitor depression severity in recurrent GP consultations in primary care - does it really make a difference? A randomised controlled study. BMC Fam Pract (2017) 0.75

Psychometric evaluation of the Malay version of the Montgomery- Asberg Depression Rating Scale (MADRS-BM). BMC Psychiatry (2015) 0.75

The impact of internet-based cognitive behavior therapy on work ability in patients with depression - a randomized controlled study. Int J Gen Med (2017) 0.75

Articles cited by this

A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89

An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61

A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care (1994) 19.87

The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry (2003) 13.60

Affective disorders and suicide risk: a reexamination. Am J Psychiatry (2000) 4.63

Zung, Beck, and Hamilton Rating Scales as measures of treatment outcome: a meta-analytic comparison. J Consult Clin Psychol (1986) 4.08

The enduring psychosocial consequences of mania and depression. Am J Psychiatry (1993) 2.45

An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument. Med Care (1997) 2.30

A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS). J Affect Disord (2001) 1.88

The Carroll rating scale for depression. I. Development, reliability and validation. Br J Psychiatry (1981) 1.61

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol (2005) 1.28

Placebo-controlled efficacy of antidepressants in continuation treatment. Int Clin Psychopharmacol (1994) 1.06

Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant. Am J Psychiatry (2000) 1.02

The relationship between homework compliance and treatment outcomes among older adult outpatients with mild-to-moderate depression. Am J Geriatr Psychiatry (2003) 0.98

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder. J Clin Psychiatry (2004) 0.97

Validation of an IVRS version of the MADRS. J Psychiatr Res (2005) 0.92

The Carroll rating scale for depression. II. Factor analyses of the feature profiles. Br J Psychiatry (1981) 0.91

The Carroll rating scale for depression. III. Comparison with other rating instruments. Br J Psychiatry (1981) 0.87

Articles by these authors

(truncated to the top 100)

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood (2006) 3.00

Guidelines for submitting adverse event reports for publication. Drug Saf (2007) 2.38

Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med (2012) 2.16

The effects of coffee and napping on nighttime highway driving: a randomized trial. Ann Intern Med (2006) 2.04

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf (2009) 1.96

Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol (2009) 1.72

Fatigue, sleep restriction and driving performance. Accid Anal Prev (2005) 1.60

Differences between clinical trials and postmarketing use. Br J Clin Pharmacol (2004) 1.54

Inhibition of Cell Growth and Cellular Protein, DNA and RNA Synthesis in Human Hepatoma (HepG2) Cells by Ethanol Extract of Abnormal Savda Munziq of Traditional Uighur Medicine. Evid Based Complement Alternat Med (2011) 1.51

Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Br J Clin Pharmacol (2006) 1.47

Rates of spontaneous reporting of adverse drug reactions in France. JAMA (2002) 1.45

Fluvastatin reduces cardiac mortality in patients with coronary heart disease. Cardiovasc Drugs Ther (2004) 1.40

Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging (2008) 1.39

Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol (2004) 1.39

Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf (2007) 1.37

Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol (2005) 1.33

Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda. Therapie (2004) 1.28

Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells. Fundam Clin Pharmacol (2005) 1.27

Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage. Fundam Clin Pharmacol (2004) 1.24

Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf (2007) 1.23

Endoscopic endonasal minimal access approach to the clivus: case series and technical nuances. Neurosurgery (2010) 1.20

Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf (2009) 1.20

Endoscopic endonasal transclival resection of chordomas: operative technique, clinical outcome, and review of the literature. J Neurosurg (2010) 1.18

Age, performance and sleep deprivation. J Sleep Res (2004) 1.17

Benzodiazepine use and risk of dementia: a nested case-control study. J Clin Epidemiol (2002) 1.15

Fatigue, sleepiness, and performance in simulated versus real driving conditions. Sleep (2005) 1.14

Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol (2007) 1.10

Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Ther Drug Monit (2005) 1.10

The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf (2009) 1.10

Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS. Clin Chim Acta (2011) 1.07

Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, May Prevent 1,2-dimethylhydrazine-Induced Rat Colon Carcinogenesis. Evid Based Complement Alternat Med (2011) 1.04

Aging and nocturnal driving: better with coffee or a nap? A randomized study. Sleep (2007) 1.00

High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose. Ther Drug Monit (2003) 0.99

Fatigue, sleep restriction, and performance in automobile drivers: a controlled study in a natural environment. Sleep (2003) 0.99

Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production. J Pharm Biomed Anal (2006) 0.98

Ethanol Extract of Abnormal Savda Munziq, a Herbal Preparation of Traditional Uighur Medicine, Inhibits Caco-2 Cells Proliferation via Cell Cycle Arrest and Apoptosis. Evid Based Complement Alternat Med (2011) 0.98

Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice. Toxicol Appl Pharmacol (2004) 0.97

Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study. J Urol (2004) 0.97

Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice. BMC Complement Altern Med (2012) 0.96

Medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in France. Fundam Clin Pharmacol (2009) 0.96

Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo. Thromb Res (2003) 0.95

Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death. Drug Saf (2005) 0.95

Antihypertensive effects of Ocimum basilicum L. (OBL) on blood pressure in renovascular hypertensive rats. Hypertens Res (2010) 0.95

Sleepiness, near-misses and driving accidents among a representative population of French drivers. J Sleep Res (2010) 0.95

Maintenance of wakefulness test as a predictor of driving performance in patients with untreated obstructive sleep apnea. Sleep (2007) 0.95

Improving pharmacovigilance in Europe. BMJ (2010) 0.94

The impact of the Uighur medicine abnormal savda munziq on antitumor and antioxidant activity in a S180 and Ehrlich ascites carcinoma mouse tumor model. Pharmacogn Mag (2012) 0.94

Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study. Acta Ophthalmol (2012) 0.94

Risk of injurious road traffic crash after prescription of antidepressants. J Clin Psychiatry (2012) 0.93

[Study on mechanism of abnormal savda munziq flavonoids in induction of apoptosis of Hep2 cells]. Zhongguo Zhong Yao Za Zhi (2007) 0.93

The risk of cognitive impairment in older community-dwelling women after benzodiazepine use. Age Ageing (2008) 0.93

Administrative complexities for a European observational study despite directives harmonising requirements. Pharmacoepidemiol Drug Saf (2012) 0.93

Anti-inflammatory, immunomodulatory, and heme oxygenase-1 inhibitory activities of ravan napas, a formulation of uighur traditional medicine, in a rat model of allergic asthma. Evid Based Complement Alternat Med (2010) 0.93

A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pharmacoepidemiol Drug Saf (2010) 0.92

Sleep duration and caffeine consumption in a French middle-aged working population. Sleep Med (2005) 0.92

Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol (2010) 0.91

Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients. Schizophr Res (2002) 0.91

A new method for assessing drug causation provided agreement with experts' judgment. J Clin Epidemiol (2006) 0.91

Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial. Arthritis Res Ther (2009) 0.90

Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk. Drug Saf (2013) 0.90

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries. Eur J Clin Pharmacol (2012) 0.89

Preventive and curative effect of Trigonella foenum-graecum L. seeds in C57BL/6J models of type 2 diabetes induced by high-fat diet. J Ethnopharmacol (2012) 0.89

Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea. Clin Gastroenterol Hepatol (2008) 0.89

Drug interactions between inhaled corticosteroids and enzymatic inhibitors. Eur J Clin Pharmacol (2009) 0.89

Botulinum toxin treatment in neurological practice: how much does it really cost? A prospective cost-effectiveness study. J Neurol (2011) 0.88

Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study. Drug Saf (2013) 0.88

Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre. Drug Saf (2010) 0.87

Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France. Drug Saf (2012) 0.87

The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf (2005) 0.87

Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Med (2007) 0.87

Concordance between prescriber- and patient-reported previous medical history and NSAID indication in the CADEUS cohort. Pharmacoepidemiol Drug Saf (2010) 0.87

A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France. Drug Saf (2013) 0.87

Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France. Br J Clin Pharmacol (2014) 0.86

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Arthritis Res Ther (2005) 0.85

Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT). Eur J Clin Pharmacol (2012) 0.85

Factors associated with serious traffic crashes: a prospective study in southwest France. Arch Intern Med (2012) 0.84

Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases. Pharmacoepidemiol Drug Saf (2013) 0.84

Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan. Biomacromolecules (2009) 0.84

Factors associated with persistence of cholinesterase inhibitor treatments in the elderly. Pharmacoepidemiol Drug Saf (2010) 0.84

High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma. Ther Drug Monit (2002) 0.84

Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals. Pharmacoepidemiol Drug Saf (2011) 0.83

Treatment of high fat diet induced type 2 diabetes in C57BL/6J mice by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol (2010) 0.83

Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males. Br J Nutr (2007) 0.82

Nocturnal sustained attention during sleep deprivation can be predicted by specific periods of subjective daytime alertness in normal young humans. J Sleep Res (2006) 0.82

Impact of prescriber nonresponse on patient representativeness. Epidemiology (2008) 0.82

Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole blood. J Anal Toxicol (2007) 0.82

Physicochemical characteristics and bronchial epithelial cell cytotoxicity of Folpan 80 WG(R) and Myco 500(R), two commercial forms of folpet. Part Fibre Toxicol (2007) 0.82

A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding. Br J Clin Pharmacol (2008) 0.82

Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation. Eur J Clin Pharmacol (2014) 0.81

The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers. Br J Clin Pharmacol (2009) 0.81

Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies. Expert Opin Drug Saf (2014) 0.81

Cutaneous adverse effects of ketoprofen for topical use: clinical patterns and costs. Am J Clin Dermatol (2010) 0.81

Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model. Fundam Clin Pharmacol (2004) 0.80

Bioavailability of glycitein relatively to other soy isoflavones in healthy young Caucasian men. Food Chem (2012) 0.80

Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones. Br J Nutr (2009) 0.80

Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study. Ann Endocrinol (Paris) (2012) 0.80

Acute and sub-chronic (28days) oral toxicity evaluation of hydroethanolic extract of Bridelia ferruginea Benth root bark in male rodent animals. Food Chem Toxicol (2012) 0.79

A large simple clinical trial prototype for assessment of OTC drug effects using patient-reported data. Pharmacoepidemiol Drug Saf (2005) 0.79

Effect of Armagnac fractions on human platelet aggregation in vitro and on rat arteriovenous shunt thrombosis in vivo probably not related only to polyphenols. Thromb Res (2006) 0.79

Pharmacokinetic interaction between high-dose methotrexate and oxacillin. Ther Drug Monit (2002) 0.79